Concepedia

Publication | Open Access

Two‐year results of a low‐dose drug‐coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first‐in‐human study

91

Citations

14

References

2015

Year

Abstract

The Stellarex DCB provides safe and durable clinical outcomes for treatment of femoropopliteal artery disease through 24 months.

References

YearCitations

Page 1